Collaboration in pharma and successful tech-transfer

The speakers will share with us some of their insights in drug development, the challenges and pitfalls, hoping that their experience will contribute to the development process of new drugs.

This time we will host international guests that will share with us the different aspects of working in a multicultural environment and bridging the gaps.
In addition, we will be discussing how to scale-up a technological process with a facile tech-transfer.

The speakers

Peter Halkjaer-Knudsen, Vice President at Raybow Pharma: "Collaboration between pharma companies in different cultures"

Anders Hogdin, Senior Sales Director at Recipharm: ״From mg to kg of your substance; first steps towards a scalable process״

Alex Weisman, CEO of Calathea Pharma: "IP associated risks in outsourcing"

Roundtable discussion: The obstacles when working with different CROs/CDMOs and tech transfer